HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

NCT05787418 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: HH-120 Nasal Spray
DRUG: Placebo

Sponsor

Huahui Health